STEM CELL RES THER 润色咨询

Stem Cell Research & Therapy

出版年份:2010 年文章数:2925 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:6.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2025-02-20 ms1000000560525324 来自浙江省

    1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2021-05-10 krygios

    偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration
    经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒

    11

    展开11条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2026-04-23 ms2000000030700368 来自贵州省

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2025-03-20 ms7000000466366687 来自安徽省

    偏重的研究方向:诱导多能干细胞;干细胞
    经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2022-07-06 ms3000000510280882

    更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。

    25

    展开25条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2025-05-12 146e9a12m86暂无昵称 来自广东省

    偏重的研究方向:干细胞治疗
    经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2025-03-27 fyx000 来自浙江省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:干细胞;肝纤维化
    经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2024-12-04 ms5000000432764812 来自北京

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:肺纤维化;间充质干细胞
    经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2025-03-29 ms5000002977722153 来自上海

    偏重的研究方向:干细胞研究领域
    经验分享:历时 近5个月最终被接收。
    现在整理一些内容分享给大家供大家参考:
    11月2号投稿,3天后收到编辑部伦理审查补充要求。
    经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折
    最终接收前完成。

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2258312, encodeId=6fd8225831201, content=偏重的研究方向:干细胞研究领域<br>经验分享:历时 近5个月最终被接收。<br>现在整理一些内容分享给大家供大家参考:<br>11月2号投稿,3天后收到编辑部伦理审查补充要求。<br>经历了三轮的修改:第一轮3位审稿人,其中2位给了正面意见,最后一位提出质疑。第二次,前两位都认可,第3位审稿人还是拒稿立场,针对方法质疑撰写了一篇小作文一一解释说明。第三轮投回去都没意见了,真是一波三折<br>最终接收前完成。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722153, createdTime=Sat Mar 29 16:45:15 CST 2025, time=2025-03-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2255222, encodeId=8a8d225522228, content=10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/xl455UN0qeMyicQhF1s8icbp3dGs6RQfhhqUl1TDu7jsL4ib1xsYKpvw4Vw4LbM2gXSWfjOo48iayK6FujmRqkrEuw/132, createdBy=24452532302, createdName=jinxi6656, createdTime=Sat Mar 08 16:11:46 CST 2025, time=2025-03-08, status=1, ipAttribution=江苏省)]
    2025-03-08 jinxi6656 来自江苏省

    10.16投稿,11.1和2.6分别大修了两次,系统显示2.9 editor assigned,已经快一个月了还没有变化。。等的焦急啊

    5

    展开5条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分